公开(公告)号：US20230391831A1

公开(公告)日：2023-12-07

申请号：US18032080

申请日：2021-10-13

Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY

Inventor： Alexandra Lucas ,  Liqiang Zhang ,  Jordan Yaron

IPC: C07K14/005 ,  A61K45/06 ,  A61K9/00 ,  A61P17/02

CPC classification number: C07K14/005 ,  A61K45/06 ,  A61K9/0014 ,  A61P17/02 ,  A61K38/00

Abstract: Wound healing is a process by which these wounds on the skin of a subject heal and eventually close. When the injured surface is large, becomes infected, or in patients with poor healing capacity such as diabetics or the elderly or bedridden patients, then wound healing can be prolonged and lead to chronic ulceration and further complications with even limb loss or increased morbidity and mortality. This invention is directed to a topical formulation for promoting wound healing, and wound dressings and bandages comprising the same.

公开(公告)号：US12029777B2

公开(公告)日：2024-07-09

申请号：US17422718

申请日：2020-01-13

Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY

Inventor： Alexandra Lucas ,  Jordan Yaron ,  Efrem Lim

IPC: A61K38/10 ,  A61K38/00

CPC classification number: A61K38/10 ,  A61K38/005

Abstract: Disclosed herein is are methods of preventing, reducing or inhibiting a viral or immune disorder, comprising administering to a subject at risk or that has acquired a viral or immune disorder an effective amount of a composition comprising a polypeptide derived from a reactive center loop of a serine protease inhibitor or a biologically active variant thereof, wherein the subject has not been administered antibiotics within at least one day of administering the composition. Also disclosed are compositions and kits for preventing, reducing or inhibiting a viral or immune disorder.

公开(公告)号：US20220088117A1

公开(公告)日：2022-03-24

申请号：US17422718

申请日：2020-01-13

Applicant: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY

Inventor： Alexandra Lucas ,  Jordan Yaron ,  Efrem Lim

IPC: A61K38/10 ,  A61K38/00

Abstract: Disclosed herein is are methods of preventing, reducing or inhibiting a viral or immune disorder, comprising administering to a subject at risk or that has acquired a viral or immune disorder an effective amount of a composition comprising a polypeptide derived from a reactive center loop of a serine protease inhibitor or a biologically active variant thereof, wherein the subject has not been administered antibiotics within at least one day of administering the composition. Also disclosed are compositions and kits for preventing, reducing or inhibiting a viral or immune disorder.